INTEGRATED ROSS SC13G 5-31-05

Company

ORAMED PHARMACEUTICALS INC.

Filed

July 20, 2005

Accession Number

0001214782-05-000267

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →